158 related articles for article (PubMed ID: 7535440)
1. T-cell depletion from allogeneic bone marrow by counterflow centrifugation is not associated with a substantial loss of CD34-positive cells.
Preijers F; Ruijs P; Schattenberg A; de Witte T
Prog Clin Biol Res; 1994; 389():339-44. PubMed ID: 7535440
[No Abstract] [Full Text] [Related]
2. The clinical use of elutriation and positive stem cell selection columns to engineer the lymphocyte and stem cell composition of the allograft.
Noga SJ; Davis J; Schepers K; Eby L; Berenson RJ
Prog Clin Biol Res; 1994; 389():317-24. PubMed ID: 7535437
[No Abstract] [Full Text] [Related]
3. Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cells.
Preijers FW; van Hennik PB; Schattenberg A; Ruijs P; Ploemacher RE; de Witte T
Bone Marrow Transplant; 1999 May; 23(10):1061-70. PubMed ID: 10373074
[TBL] [Abstract][Full Text] [Related]
4. Enrichment of bone marrow and blood progenitor (CD34+) cells by density gradients with sufficient yields for transplantation.
Schriber JR; Dejbakhsh-Jones S; Kusnierz-Glaz CR; Ginzton N; Still B; Negrin RS; Greenberg P; Strober S
Exp Hematol; 1995 Aug; 23(9):1024-9. PubMed ID: 7543414
[TBL] [Abstract][Full Text] [Related]
5. The effect of PIXY-321 on 4-hydroperoxycyclophosphamide purged and CD34+ positively selected bone marrow.
Hami LS; Shpall EJ; Johnston CS; Berenson R; Jones RB
Prog Clin Biol Res; 1992; 377():321-5. PubMed ID: 1279709
[No Abstract] [Full Text] [Related]
6. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
[TBL] [Abstract][Full Text] [Related]
7. Development of an immunomagnetic separation procedure to deplete V alpha beta-positive T cells from marrow for use in partially mismatched related donor (PMRD) transplantation.
Lamb L; Metherell J; Lee C; Brouillette M; Thompson J; Brown S; Henslee-Downey PJ; Gee A
Prog Clin Biol Res; 1994; 389():541-50. PubMed ID: 7700919
[No Abstract] [Full Text] [Related]
8. A new 'two step' procedure for 4.5 log depletion of T and B cells in allogeneic transplantation and of neoplastic cells in autologous transplantation.
Bertolini F; Thomas T; Battaglia M; Gibelli N; Pedrazzoli P; Robustelli della Cuna G
Bone Marrow Transplant; 1997 Mar; 19(6):615-9. PubMed ID: 9085741
[TBL] [Abstract][Full Text] [Related]
9. [CD34+ cells in the autotransplant of bone marrow and peripheral blood].
Silvestri F; Baccarani M
Recenti Prog Med; 1992 Feb; 83(2):89-92. PubMed ID: 1380174
[TBL] [Abstract][Full Text] [Related]
10. Impact of the degree of maturation and differentiation of CD34+ cells in grafts of different origin on the duration of aplasia.
Wunder E; Sovalat H; Liang H; Becker M; Henon P
Prog Clin Biol Res; 1994; 389():345-50. PubMed ID: 7535441
[No Abstract] [Full Text] [Related]
11. New technology for the depletion of T cells from soybean lectin agglutinated, HLA-matched bone marrow grafts for leukemia: initial laboratory and clinical results.
Collins NH; Carabasi MH; Bleau S; Jagiello C; Young JW; Castro-Malaspina H; Flomenberg N; Papadopoulos EB; Emanuel D; Gillio A
Prog Clin Biol Res; 1992; 377():427-39. PubMed ID: 1438441
[No Abstract] [Full Text] [Related]
12. Effect of depletion of class II bright cells on the immunogenicity and stem cell content of human vertebral body bone marrow.
Kenyon NS; Xu XM; Garcia-Serra A; Ricordi C
Transplant Proc; 1995 Dec; 27(6):3419. PubMed ID: 8540031
[No Abstract] [Full Text] [Related]
13. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
14. Campath-1M antibodies for T cell depletion of haploidentical marrow transplanted to children with malignant osteopetrosis.
Fasth A; Porras O; Baltorano A; Carrillo J; Gonzales L; Odio C; de los Angeles Umaña M
Prog Clin Biol Res; 1992; 377():399-403. PubMed ID: 1438436
[No Abstract] [Full Text] [Related]
15. Graft versus host tolerance in dogs across one DLA-haplotype by depletion of CD6 positive cells.
Schumm M; Kolb HJ; Hahn J; Beisser K; Rieber P; Günther W; Büttner M; Wilmanns W; Thierfelder S
Prog Clin Biol Res; 1992; 377():419-25. PubMed ID: 1438440
[No Abstract] [Full Text] [Related]
16. CD34 positive cell selection by immunomagnetic techniques.
Bigas A; Amill B; Canals C; Tugues D; García J
Prog Clin Biol Res; 1992; 377():545-51. PubMed ID: 1279723
[No Abstract] [Full Text] [Related]
17. Comparison of T cell depletion strategies from bone marrow, umbilical cord and peripheral blood using five separation systems.
Feugier P; Thévenin S; Billot M; Serrurier B; Loigerot C; Schooneman F; Janot C; Hervé P; Racadot E
Hematol Cell Ther; 1997 Apr; 39(2):67-73. PubMed ID: 9168302
[TBL] [Abstract][Full Text] [Related]
18. Use of Ceprate CD34-positive selection system for depletion of T cells in allogeneic transplantation.
Hale G; Waldmann H
Bone Marrow Transplant; 1997 Oct; 20(8):709-10. PubMed ID: 9383240
[No Abstract] [Full Text] [Related]
19. Selective T cell depletion of donor allogeneic marrow with anti-CD6 monoclonal antibody: rationale and results.
Soiffer RJ; Ritz J
Bone Marrow Transplant; 1993; 12 Suppl 3():S7-10. PubMed ID: 8124262
[TBL] [Abstract][Full Text] [Related]
20. Development of a large-scale immunomagnetic separation system for harvesting CD34-positive cells from bone marrow.
Hardwick A; Law P; Mansour V; Kulcinski D; Ishizawa L; Gee A
Prog Clin Biol Res; 1992; 377():583-9. PubMed ID: 1279728
[No Abstract] [Full Text] [Related]
[Next] [New Search]
